CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC
Summary
Pfizer-sponsored master protocol evaluating treatment patterns, medication adherence, and health and economic outcomes in renal cell carcinoma; the study is com…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Pfizer | Conditions: Renal Cell Carcinoma (RCC) | Status: COMPLETED | Results posted: 2024-09-19